Asia-Pacific Presbyopia Market Outlook 2028

  • Product Code:
    RP-ID-10346769
  • Published Date:
    21 Oct 2022
  • Region:
    Global
  • Pages:
    101
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-9

Impact Analysis on the Growth of Market

Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

..

..

The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Translate Report

Asia-Pacific Presbyopia Treatment Market Analysis 2019-2028
Presbyopia is the progressive deterioration of the eyes to concentrate on surrounding objects. It typically becomes visible in the early to mid-40s and begins to deteriorate until around 65 years of age. The Asia-Pacific presbyopia treatment market accounted for a market value of around USD 1700 million in 2019 and is anticipated to reach around USD 3600 million by 2028, by growing at a CAGR of 8.51% during the forecast period i.e. 2020-2028. Since presbyopia is a lens-based condition, majority of the future solutions are based on the development of intraocular lenses. The future technologies include adjustable intraocular lenses, multifocal intraocular lenses, and others.
Owing to the rising number of people suffering from presbyopia and the growing geriatric population, the Asia-Pacific presbyopia treatment market is anticipated to expand rapidly over the forecast period. Key players in the presbyopia market in Asia-Pacific are focusing on developments and improvements in presbyopia treatment. The companies provide approved products in the market to increase credibility and brand value in the market. In addition, various manufacturers across the region are adopting massive developments such as user-friendly designs, software upgrades for improved visualization and treatment procedures. Rapidly growing internet penetration across Asia-Pacific countries is making it possible for enterprises to reach out where members are not present at all.
The Asia-Pacific presbyopia treatment market consists of various segments that are segmented by age group and treatment type. The market is further segmented by age group less than 40, 40-60-year-old, above 60. Out of these, the 40-60-year-old segment accounted for the largest market share of around 60% in the Asia-Pacific presbyopia treatment market in 2019. Difficulty in reading small print, having to hold reading material farther away, headaches, and eyestrain are some of the symptoms of presbyopia.
On the basis of treatment type, the market is segmented into corrective eyeglasses, contact lenses, refractive surgery, lens implants, and pharmacological treatment. Among them, the corrective eyeglasses segment accounted for the largest market share in 2019. Bifocal eyeglasses or progressive lens eyeglasses are most commonly prescribed by doctors. Typically, a bifocal lens is broken into two parts. To fix distant vision, the larger portion is used, while the smaller lens helps the patient to see up and near. In addition, eyeglasses are considered the easiest and most secure method of treating presbyopia.
Some of the affluent leaders in the Asia-Pacific presbyopia treatment market are NIDEK CO., LTD, Johnson & Johnson Vision Care, Inc., Alcon Vision LLC, Carl Zeiss AG, Bausch & Lomb Incorporated, Essilor International, Ziemer Ophthalmic Systems AG, Topcon Corporation, Novartis AG and others.






 


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

NIDEK CO., LTD, Johnson & Johnson Vision Care, Inc., Alcon Vision LLC, Carl Zeiss AG, Bausch & Lomb Incorporated, Essilor International, Ziemer Ophthalmic Systems AG, Topcon Corporation, Novartis AG and others.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports

-->